| scholarly article | Q13442814 |
| P2093 | author name string | J L Mehta | |
| F Romeo | |||
| T G Saldeen | |||
| K Ericson | |||
| E Martuscelli | |||
| G Chirieolo | |||
| L M Cerabino | |||
| P2860 | cites work | The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae | Q33843538 |
| Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old) | Q34086738 | ||
| Growth of Chlamydia psittaci in macrophages | Q34465881 | ||
| Chlamydia pneumoniae antibodies are associated with an atherogenic lipid profile | Q35370873 | ||
| Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells | Q35488540 | ||
| Herpes simplex virus infection in human arterial cells. Implications in arteriosclerosis | Q35581408 | ||
| In vitro susceptibility of human vascular wall cells to infection with Chlamydia pneumoniae | Q36524413 | ||
| Detection and widespread distribution of Chlamydia pneumoniae in the vascular system and its possible implications | Q37214056 | ||
| Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamyd | Q37878769 | ||
| Lack of association between prior infection with Chlamydia pneumoniae and acute or chronic coronary artery disease | Q37878909 | ||
| Poor correlation between microimmunofluorescence serology and polymerase chain reaction for detection of vascular Chlamydia pneumoniae infection in coronary artery disease patients. | Q37879706 | ||
| Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction | Q37880581 | ||
| Interactive role of infection, inflammation and traditional risk factors in atherosclerosis and coronary artery disease | Q37881093 | ||
| Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model | Q37881464 | ||
| Chronic Chlamydia pneumoniae infection is associated with a serum lipid profile known to be a risk factor for atherosclerosis | Q37881850 | ||
| Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS Pilot Study. ROXIS Study Group | Q37882250 | ||
| Chlamydia pneumoniae and acute myocardial infarction in Jerusalem | Q37882349 | ||
| Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction | Q37882420 | ||
| Chlamydia species infect human vascular endothelial cells and induce procoagulant activity | Q37883093 | ||
| Murine models of Chlamydia pneumoniae infection and atherosclerosis | Q37883205 | ||
| Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. The Chlamydia pneumoniae/Atherosclerosis Study Group | Q37883953 | ||
| Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease | Q37884972 | ||
| Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy | Q37885296 | ||
| Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. | Q37886690 | ||
| Lp(a) lipoprotein, IgG, IgA and IgM antibodies to Chlamydia pneumoniae and HLA class II genotype in early coronary artery disease | Q37887196 | ||
| Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques | Q37892518 | ||
| Chlamydia pneumoniae strain TWAR antibody and angiographically demonstrated coronary artery disease | Q37894988 | ||
| Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction | Q37899465 | ||
| The National Cholesterol Education Program: progress and prospects | Q77754878 | ||
| P433 | issue | 5 | |
| P921 | main subject | atherosclerosis | Q12252367 |
| Chlamydia pneumoniae | Q62869737 | ||
| P304 | page(s) | 327-330 | |
| P577 | publication date | 2000-05-01 | |
| P1433 | published in | Clinical Cardiology | Q4502312 |
| P1476 | title | Seropositivity against Chlamydia pneumoniae in patients with coronary atherosclerosis | |
| P478 | volume | 23 |
| Q36783331 | Chlamydophila pneumoniae infection and cardiovascular disease |
| Q79299394 | Chronic infection and coronary artery disease |
| Q35165193 | Inflammation, infection, and atherosclerosis |
| Q36817684 | Is there any relationship between Chlamydophila pneumoniae and coronary atherosclerosis among Iranians? |
| Q36265876 | Lipoprotein (A): Better assessor of coronary heart disease risk in south Indian population |
| Q34874476 | Role of antibiotics for the prevention of cardiovascular disease |
Search more.